Next Financial Group’s Supernus Pharmaceuticals SUPN Stock Holding History

Next Financial Group’s Portfolio SUPN Stock Details SUPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$15K	Buy	511 +326	+176%	+$9.89K	﹤0.01%	2014
2021 Q3	$5K	Buy	185 +85	+85%	+$2.28K	﹤0.01%	2277
2021 Q2	$3K	Hold	100	–	–	﹤0.01%	2350
2021 Q1	$3K	Hold	100	–	–	﹤0.01%	2257
2020 Q4	$3K	Hold	100	–	–	﹤0.01%	2133
2020 Q3	$2K	Buy	+100	New	+$2.27K	﹤0.01%	2049
2018 Q1	–	Sell	-5,720	Closed	-$228K	–	421
2017 Q4	$228K	Sell	5,720 -2,600	-31%	-$103K	0.1%	230
2017 Q3	$344K	Sell	8,320 -6,530	-44%	-$283K	0.1%	216
2017 Q2	$640K	Buy	+14,850	New	+$529K	0.16%	149

Other funds holding SUPN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

ACB

Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return

Next Financial Group's SUPN Position: Q4 2021 in Review

Next Financial Group increased its Supernus Pharmaceuticals (SUPN) stake by 176% in Q4 2021, buying an estimated $9.89K and bringing the position to 511 shares worth $15K. The position accounts for ﹤0.01% of the portfolio, ranked #2014.

Next Financial Group first reported a position in SUPN in Q2 2017 and has held it in 9 quarters since. The position peaked at $640K in Q2 2017. 235 funds tracked by Wall St. Rank hold SUPN as of Q4 2021.

Next Financial Group held 511 shares of Supernus Pharmaceuticals worth $15K as of Q4 2021.
Next Financial Group bought 326 Supernus Pharmaceuticals shares in Q4 2021, an estimated $9.89K.
Supernus Pharmaceuticals made up ﹤0.01% of Next Financial Group's portfolio in Q4 2021, its #2014 holding.
Next Financial Group first reported a position in Supernus Pharmaceuticals in Q2 2017 and has held it in 9 quarters since.
Next Financial Group's Supernus Pharmaceuticals position peaked at $640K in Q2 2017.
235 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q4 2021.

Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.